Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

Delayed Data
As of Sep 21
 -2.62 / -2.10%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 19 analysts offering 12-month price forecasts for Alexion Pharmaceuticals Inc have a median target of 165.00, with a high estimate of 188.00 and a low estimate of 123.00. The median estimate represents a +35.26% increase from the last price of 121.99.

Analyst Recommendations

The current consensus among 20 polled investment analysts is to Buy stock in Alexion Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Oct 25

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -15.95%
Growthannually 23.11%


Growthquarterly -2.54%
Growthannually 13.68%
Key to the earnings and sales forecast charts.